The biology and behaviour of a free-living population of black rats (Rattus rattus)

A population of wild Rattus rattus living in the roofs of the laboratory buildings was studied by supplying food every evening and watching the behaviour of the animals at the feeding place. Some observations were also made on caged animals. The rats were predominantly of the black rattus variety but white-bellied greys appeared now and then. In breeding tests the grey colour behaved as though determined by a single recessive gene. The study covered two periods of approximately 9 months each, separated by an interval of 3 months during which a reduced quantity of food was provided and the rat population underwent a major decline. During the two periods of richer feeding the population first increased and then stabilized at a level where the animals remained in good condition and there was no starvation. In the first 9-month period, stabilization was achieved by emigration of young adults who colonized neighbouring buildings. Towards the end of the second period, stabilization was achieved by limitation of breeding. The rats accepted a wide variety of foods, including meat, and a number of instances of predation were seen. Small vertebrates as well as insects were killed and eaten. Small pieces of food were usually eaten in situ but large bits were taken up to the nests in the roof. Such differential treatment in relation to size may be a factor of some importance in the evolution of hoarding. The rats visiting the feeding place formed a unit with a definite social structure. A single dominant male and never more than one, was always present and in certain circumstances a linear male hierarchy was formed. There were usually two or three mutually tolerant top ranking females who were subordinate to the top male but dominant to all other members of the group. Within the group attacks were directed downwards in the social scale. An attacked subordinate either fled or appeased and serious fights therefore did not develop. The most essential component of the appease. ment appeared to be a mouth to mouth contact which may be derived from the infantile pattern of 'mouth suckling'. Appeasement permitted superior rats to maintain their status without the necessity of carrying attacks on subordinates to the point where actual hurt was inflicted. A group territory round the feeding place was defended against interlopers. Both sexes took part in chasing out intruders but since males showed inhibition in attacking females, the exclusion of strange females was due principally to the activities of the home females. The point at which pursuit of an intruder stopped was regarded as the territorial boundary. This was also the limit beyond which a group member would not allow himself to be chased but it was not a prison wall. When agonistic tendencies were not aroused the animals no longer always I turned back at the boundary and foraging beyond its limits allowed them to become familiar with an area larger than the territory. Although intruders were normally driven out, it was occasionally possible for a particularly determined animal of either sex to force its way in and ultimately become a member of the group. The patterns of behaviour seen are described, particularly those concerned with hostile encounters and with mating. Scent marking with urine drip trails was not seen but adults of both sexes marked by rubbing the cheeks and ventral surface on branches. The circumstances in which tooth gnashing was heard suggest that this behaviour is not a form of threat but a response to unfamiliar auditory or visual stimuli. There was some evidence that it functioned as an alarm signal within the group. Pilo-erection and a gait or posture with the hind legs much extended ('stegosauring') are considered to function as threats. Pilo-erection occurred in situations where there was little to suggest conflict and is considered to represent a form of threat which has undergone emancipation. Various forms of displacement and ambivalent behaviour were seen. Rapid vibration of the tail occurred in thwarting situations, either during mating or when a defeated opponent suddenly vanished. There was no evidence that it acted as a signal. The common form of amicable behaviour was social grooming. Another amicable action was sitting together with the bodies in contact. Animals reared in cages remained shy and wary and even hand reared young developed the usual alarm responses to movement and noises. Females had their first litters at ages of 3 to 5 months. For first litters gestation periods were 21 to 22 days but in females that were simultaneously lactating they ranged from 23 to 29 days. Eight was the commonest litter number and ten the highest recorded. At birth the tail is very much shorter than the body but has outstripped it by the time the youngster emerges from the nest. This was found to be the result of a period of extremely rapid tail growth immediately preceding emergence. In Rattus norvegicus the peak in tail growth rate was found to be later and less striking. The difference is interpreted as related to the importance of the tail in climbing in the more arboreal R. rattus. During the second week of life an edge response (retreat from a declivity) and a clinging response made their appearance: these have the function of preventing accidental falls from a nest situated above ground level. Mouth suckling was seen only during a period of a few days towards the end of lactation. Play developed within a few days of emergence from the nest: locomotor and fighting play were the common types. Older animals occasionally joined in play with the young. In problem solving tests, first solutions were not insightful but once a solution had been found, the successful technique was at once adopted and subsequently perfected. There was no evidence of learning by imitation but the rats did learn from each other's behaviour that food could be obtained at a certain location and thus the solution of a problem by one rat accelerated its independent solution by others. The reasons for the differences between the behaviour of the free living population and the caged animals studied by other authors are discussed

A collection of Phacochoerus aethiopicus teeth from the Kalkbank middle stone age site, central Transvaal

Main ArticleA Middle Stone Age site at Kalkbank, near Pietersburg in the northern Transvaal, has recently been excavated for the Archaeological Survey by R. Mason: a description of the site and the archaeological findings is shortly to be published (Mason, in press). In addition to the cultural material, animal remains are abundant; the present paper deals with the Suid material which has been found at Kalkbank. This consists of a large collection of teeth, almost all isolated, comprising (apart from much damaged fragments) 53 reasonably complete third, 29 second and 10 first molars, together with 29 upper and 25 lower canines and a single last milk molar. As will be shown later, this material is all referable to the extinct Phacochoerus aethiopicus (Pallas). It constitutes the best collection of material of this species from a single locality that is at present available for study, and therefore adds something to our knowledge of the characteristics of the dentition of this species.The South African Council for Scientific and Industrial Researc

Discourse on the National Crisis

Full title: Discourse on the National Crisis, delivered by the Rev. F. C. Ewer, at St. Ann\u27s Church, New York, on the evening of the fifth Sunday after Easter, (May 5,) and repeated, by request, on the evening of the Sunday after Ascension, (May 12,) 1861https://digitalcommons.cedarville.edu/pamphlet_collection/1091/thumbnail.jp

Comparative Morphology of the Penis and Clitoris in Four Species of Moles (Talpidae).

The penile and clitoral anatomy of four species of Talpid moles (broad-footed, star-nosed, hairy-tailed, and Japanese shrew moles) were investigated to define penile and clitoral anatomy and to examine the relationship of the clitoral anatomy with the presence or absence of ovotestes. The ovotestis contains ovarian tissue and glandular tissue resembling fetal testicular tissue and can produce androgens. The ovotestis is present in star-nosed and hairy-tailed moles, but not in broad-footed and Japanese shrew moles. Using histology, three-dimensional reconstruction, and morphometric analysis, sexual dimorphism was examined with regard to a nine feature masculine trait score that included perineal appendage length (prepuce), anogenital distance, and presence/absence of bone. The presence/absence of ovotestes was discordant in all four mole species for sex differentiation features. For many sex differentiation features, discordance with ovotestes was observed in at least one mole species. The degree of concordance with ovotestes was highest for hairy-tailed moles and lowest for broad-footed moles. In relationship to phylogenetic clade, sex differentiation features also did not correlate with the similarity/divergence of the features and presence/absence of ovotestes. Hairy-tailed and Japanese shrew moles reside in separated clades, but they exhibit a high degree of congruence. Broad-footed and hairy-tailed moles reside within the same clade but had one of the lowest correlations in features and presence/absence of ovotestes. Thus, phylogenetic affinity and the presence/absence of ovotestes are poor predictors for most sex differentiation features within mole external genitalia

Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial

Background Infections acquired in hospital are an important cause of morbidity and mortality in very preterm infants. Several small trials have suggested that supplementing the enteral diet of very preterm infants with lactoferrin, an antimicrobial protein processed from cow's milk, prevents infections and associated complications. The aim of this large randomised controlled trial was to collect data to enhance the validity and applicability of the evidence from previous trials to inform practice. Methods In this randomised placebo-controlled trial, we recruited very preterm infants born before 32 weeks' gestation in 37 UK hospitals and younger than 72 h at randomisation. Exclusion criteria were presence of a severe congenital anomaly, anticipated enteral fasting for longer than 14 days, or no realistic prospect of survival. Eligible infants were randomly assigned (1:1) to receive either enteral bovine lactoferrin (150 mg/kg per day; maximum 300 mg/day; lactoferrin group) or sucrose (same dose; control group) once daily until 34 weeks' postmenstrual age. Web-based randomisation minimised for recruitment site, gestation (completed weeks), sex, and single versus multifetal pregnancy. Parents, caregivers, and outcome assessors were unaware of group assignment. The primary outcome was microbiologically confirmed or clinically suspected late-onset infection (occurring >72 h after birth), which was assessed in all participants for whom primary outcome data was available by calculating the relative risk ratio with 95% CI between the two groups. The trial is registered with the International Standard Randomised Controlled Trial Number 88261002. Findings We recruited 2203 participants between May 7, 2014, and Sept 28, 2017, of whom 1099 were assigned to the lactoferrin group and 1104 to the control group. Four infants had consent withdrawn or unconfirmed, leaving 1098 infants in the lactoferrin group and 1101 in the sucrose group. Primary outcome data for 2182 infants (1093 [99·5%] of 1098 in the lactoferrin group and 1089 [99·0] of 1101 in the control group) were available for inclusion in the modified intention-to-treat analyses. 316 (29%) of 1093 infants in the intervention group acquired a late-onset infection versus 334 (31%) of 1089 in the control group. The risk ratio adjusted for minimisation factors was 0·95 (95% CI 0·86–1·04; p=0·233). During the trial there were 16 serious adverse events for infants in the lactoferrin group and 10 for infants in the control group. Two events in the lactoferrin group (one case of blood in stool and one death after intestinal perforation) were assessed as being possibly related to the trial intervention. Interpretation Enteral supplementation with bovine lactoferrin does not reduce the risk of late-onset infection in very preterm infants. These data do not support its routine use to prevent late-onset infection and associated morbidity or mortality in very preterm infants. Funding UK National Institute for Health Research Health Technology Assessment programme (10/57/49)

Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial

Background Infections acquired in hospital are an important cause of morbidity and mortality in very preterm infants. Several small trials have suggested that supplementing the enteral diet of very preterm infants with lactoferrin, an antimicrobial protein processed from cow's milk, prevents infections and associated complications. The aim of this large randomised controlled trial was to collect data to enhance the validity and applicability of the evidence from previous trials to inform practice. Methods In this randomised placebo-controlled trial, we recruited very preterm infants born before 32 weeks' gestation in 37 UK hospitals and younger than 72 h at randomisation. Exclusion criteria were presence of a severe congenital anomaly, anticipated enteral fasting for longer than 14 days, or no realistic prospect of survival. Eligible infants were randomly assigned (1:1) to receive either enteral bovine lactoferrin (150 mg/kg per day; maximum 300 mg/day; lactoferrin group) or sucrose (same dose; control group) once daily until 34 weeks' postmenstrual age. Web-based randomisation minimised for recruitment site, gestation (completed weeks), sex, and single versus multifetal pregnancy. Parents, caregivers, and outcome assessors were unaware of group assignment. The primary outcome was microbiologically confirmed or clinically suspected late-onset infection (occurring >72 h after birth), which was assessed in all participants for whom primary outcome data was available by calculating the relative risk ratio with 95% CI between the two groups. The trial is registered with the International Standard Randomised Controlled Trial Number 88261002. Findings We recruited 2203 participants between May 7, 2014, and Sept 28, 2017, of whom 1099 were assigned to the lactoferrin group and 1104 to the control group. Four infants had consent withdrawn or unconfirmed, leaving 1098 infants in the lactoferrin group and 1101 in the sucrose group. Primary outcome data for 2182 infants (1093 [99·5%] of 1098 in the lactoferrin group and 1089 [99·0] of 1101 in the control group) were available for inclusion in the modified intention-to-treat analyses. 316 (29%) of 1093 infants in the intervention group acquired a late-onset infection versus 334 (31%) of 1089 in the control group. The risk ratio adjusted for minimisation factors was 0·95 (95% CI 0·86–1·04; p=0·233). During the trial there were 16 serious adverse events for infants in the lactoferrin group and 10 for infants in the control group. Two events in the lactoferrin group (one case of blood in stool and one death after intestinal perforation) were assessed as being possibly related to the trial intervention. Interpretation Enteral supplementation with bovine lactoferrin does not reduce the risk of late-onset infection in very preterm infants. These data do not support its routine use to prevent late-onset infection and associated morbidity or mortality in very preterm infants. Funding UK National Institute for Health Research Health Technology Assessment programme (10/57/49)

Operationalising Positive Tipping Points towards Global Sustainability

This is the final version. Available from the Global Systems Institute, University of Exeter via the link in this recordGSI scientific working paper series number 2021/01Data Availability: The article contains no new data.Non-Technical Summary: Transforming towards global sustainability requires a dramatic acceleration of current progress. Hence there is growing interest in finding ‘positive tipping points’ at which small interventions can trigger self-reinforcing feedbacks that accelerate systemic change. Examples have recently been seen in power generation, personal transport, and lighting. But how to identify positive tipping points that have yet to occur? We synthesise theory and examples to provide initial guidelines for creating enabling conditions, sensing when a system can be positively tipped, who can trigger it, and how they can trigger it. All of us can play a part in triggering positive tipping points. Technical Summary: Recent work on positive tipping points towards sustainability has focused on social-technological systems and the agency of policymakers to tip change, whilst earlier work identified socialecological positive feedbacks triggered by diverse actors. We bring these together to consider positive tipping points across social-ecological-technological systems and the potential for multiple actors and interventions to trigger them. Established theory and examples provide several generic mechanisms for triggering tipping points. From these we identify specific enabling conditions, reinforcing feedbacks, actors, and interventions that can contribute to triggering positive tipping points in the adoption of sustainable behaviours and technologies. Actions that can create enabling conditions for positive tipping include targeting smaller populations, reducing price, improving performance, desirability and accessibility, coordinating complementary technologies, providing relevant information, and altering social network structure. Actions that can trigger positive tipping include social, ecological, and technological innovations, policy interventions, public investment, private investment, broadcasting public information, and behavioural nudges. Positive tipping points can help counter widespread feelings of disempowerment in the face of global challenges and help unlock ‘paralysis by complexity’. A key research agenda is to consider how different agents and interventions can most effectively work together to create system-wide positive tipping points whilst ensuring a just transformation.Leverhulme TrustAlan Turing Institut

Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals

<p>Abstract</p> <p>Background</p> <p>A new generation of diagnostic tests, the interferon-γ release assays (IGRAs), have been developed for the detection of latent tuberculosis infection (LTBI). Limited data are available on their use in HIV-infected persons.</p> <p>Methods</p> <p>A cross-sectional study was carried out at 2 HIV clinics in Atlanta to assess the utility of two IGRA tests (T-SPOT.TB [TSPOT] and QuantiFERON-TB Gold in Tube [QFT-3G]) compared to the tuberculin skin test (TST).</p> <p>Results</p> <p>336 HIV-infected persons were enrolled. Median CD4 count was 335 cells/μl and median HIV viral load was 400 copies/ml. Overall, 27 patients (8.0%) had at least 1 positive diagnostic test for LTBI: 7 (2.1%) had a positive TST; 9 (2.7%) a positive QFT-3G; and 14 (4.2%) a positive TSPOT. Agreement between the 3 diagnostic tests was poor: TST and TSPOT, [κ = 0.16, 95% CI (-0.06, 0.39)], TST and QFT-3G [κ = 0.23, 95% CI (-0.05, 0.51)], QFT-3G and TSPOT [κ = 0.06, 95% CI (-0.1, 0.2)]. An indeterminate test result occurred among 6 (1.8%) of QFT-3G and 47 (14%) of TSPOT tests. In multivariate analysis, patients with a CD4 ≤ 200 cells/μl were significantly more likely to have an indeterminate result [OR = 3.6, 95% CI (1.9, 6.8)].</p> <p>Conclusion</p> <p>We found a low prevalence of LTBI and poor concordance between all 3 diagnostic tests. Indeterminate test results were more likely at CD4 counts ≤ 200 cells/μl. Additional studies among HIV-infected populations with a high prevalence of TB are needed to further assess the utility of IGRAs in this patient population.</p

In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response

Background: In recent years, the impact of antituberculous treatment on interferon (IFN)-c response to Mycobacterium tuberculosis antigens has been widely investigated, but the results have been controversial. The objective of the present study was: i) to evaluate longitudinal changes of IFN-c response to M. tuberculosis-specific antigens in TB patients during antituberculous treatment by using the QuantiFERON-TB Gold (QFT-G) assay; ii) to compare the differences in T-cell response after a short or prolonged period of stimulation with mycobacterial antigens; iii) to assess the CD4+ and CD8+ T cells with effector/memory and central/memory phenotype; iv) to investigate the direct in vitro effects of antituberculous drugs on the secretion of IFN-c. Principal Findings: 38 TB patients was evaluated at baseline and at month 2 and 4 of treatment and at month 6 (treatment completion). 27 (71%) patients had a QFT-G reversion (positive to negative) at the end of therapy, while 11 (29%) TB patients remained QFT-G positive at the end of therapy. Among the 11 patients with persistent positive QFT-G results, six had a complete response to the treatment, while the remaining 5 patients did not have a resolution of the disease. All 27 patients who became QFT-G negative had a complete clinical and microbiological recovery of the TB disease. In these patients the release of IFN-c is absent even after a prolonged 6-day incubation with both ESAT-6 and CFP-10 antigens and the percentage of effector/memory T-cells phenotype was markedly lower than subjects with persistent positive QFT-G results. The in vitro study showed that antituberculous drugs did not exert any inhibitory effect on IFN-c production within the range of therapeutically achievable concentrations. Conclusions: The present study suggests that the decrease in the M. tuberculosis-specific T cells responses following successful anti-TB therapy may have a clinical value as a supplemental tool for the monitoring of the efficacy of pharmacologic intervention for active TB. In addition, the antituberculous drugs do not have any direct down-regulatory effect on the specific IFN-c response

Body surface area and baseline blood pressure predict subclinical anthracycline cardiotoxicity in women treated for early breast cancer.

BACKGROUND AND AIMS: Anthracyclines are highly effective chemotherapeutic agents which may cause long-term cardiac damage (chronic anthracycline cardiotoxicity) and heart failure. The pathogenesis of anthracycline cardiotoxicity remains incompletely understood and individual susceptibility difficult to predict. We sought clinical features which might contribute to improved risk assessment. METHODS: Subjects were women with early breast cancer, free of pre-existing cardiac disease. Left ventricular ejection fraction was measured using cardiovascular magnetic resonance before and >12 months after anthracycline-based chemotherapy (>3 months post-Trastuzumab). Variables associated with subclinical cardiotoxicity (defined as a fall in left ventricular ejection fraction of ≥5%) were identified by logistic regression. RESULTS: One hundred and sixty-five women (mean age 48.3 years at enrollment) completed the study 21.7 months [IQR 18.0-26.8] after starting chemotherapy. All received anthracyclines (98.8% epirubicin, cumulative dose 400 [300-450] mg/m2); 18% Trastuzumab. Baseline blood pressure was elevated (≥140/90mmHg, mean 147.3/86.1mmHg) in 18 subjects. Thirty-four subjects (20.7%) were identified with subclinical cardiotoxicity, independent predictors of which were the number of anthracycline cycles (odds ratio, OR 1.64 [1.17-2.30] per cycle), blood pressure ≥140/90mmHg (OR 5.36 [1.73-17.61]), body surface area (OR 2.08 [1.36-3.20] per standard deviation (0.16m2) increase), and Trastuzumab therapy (OR 3.35 [1.18-9.51]). The resultant predictive-model had an area under the receiver operating characteristics curve of 0.78 [0.70-0.86]. CONCLUSIONS: We found subclinical cardiotoxicity to be common even within this low risk cohort. Risk of cardiotoxicity was associated with modestly elevated baseline blood pressure-indicating that close attention should be paid to blood pressure in patients considered for anthracycline based chemotherapy. The association with higher body surface area suggests that indexing of anthracycline doses to surface area may not be appropriate for all, and points to the need for additional research in this area